Michael A. Fischbach, Ph.D.

Associate Professor, Department of Bioengineering,
Department of Microbiology & Immunology, Stanford University
Michael A. Fischbach’s website

Fischbach is an associate professor in Stanford University’s Bioengineering Department and the Microbiology & Immunology Department. Additionally, he is an institute scholar at Stanford ChEM-H and director of the Stanford Microbiome Therapies Initiative. Fischbach is also a co-founder and director of Federation Bio and Viralogic, a co-founder of Revolution Medicines, a member of the scientific advisory board of NGM Biopharmaceuticals, and an innovation partner at The Column Group.

Advancing Research in Basic Science and Mathematics Subscribe to our newsletters to receive news & updates